Laboratories

The Chen Ultrasound Lab combines engineering, biology, and medicine to develop innovative focused ultrasound techniques to improve the lives of patients with brain diseases.

The Greenberg lab integrates data science and biomedical informatics with clinical outcomes research and implementation science to improve care for patients with spine diseases.

The Haller Laboratory is in the Department of Neurosurgery at Washington University School of Medicine and is affiliated with the Departments of Neurology and Genetics. 

Identify the molecular signals that control normal brain development and the abnormal signals that drive brain tumors.

The goal of the Leuthardt Lab is to understand brain computer interface (BCI) devices and their implications regarding patient care.

We study disorders of cerebrospinal fluid (CSF) physiology such as hydrocephalus and Chiari-associated syringomyelia. 

The Molecular Neuro-oncology lab is focused on developing genomic and epigenomic liquid biopsy approaches for non-invasive detection of brain tumors.

The Molina Lab is devoted to the investigation, development, and clinical translation of novel technologies that have the potential to decrease surgical invasiveness and improve surgical safety, efficacy, and efficiency.

Improving movement through neurorehabilitation.

Dedicated to unraveling the intricate molecular mechanisms underlying tumors of the skull base.

The goal of the Strahle Lab is to understand germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH)-induced brain injury and hydrocephalus in order to develop targeted therapeutics to prevent hydrocephalus, mitigate brain injury, and improve outcomes in infants with GMH-IVH.

The Ray Lab is interested in the development and validation of electrode/tissue interfaces for regenerative and rehabilitative applications.

The Stegh Lab aims to understand and therapeutically target the genetic program that underlies the pathogenesis of glioblastoma.

Developing high-throughput technologies to study cell-cell interactions. Decoding the metastatic tumor microenvironment. Identifying therapeutic targets in cancer-stroma interactions to fight metastatic cancer.

The Thompson Lab investigates the molecular mechanisms of and treatment for leptomeningeal dissemination of pediatric brain tumors, focusing on the Abelson family of nonreceptor tyrosine kinases (ABL1 and ABL 2).

Focusing on characterizing the function of brain circuits that control memory and arousal in normal and disease states.

Identify molecular mechanisms of neurodegeneration in Huntington’s disease.

The YE Li Lab investigates both the genetic and epigenetic contributions to human diseases, particularly in brain tumors and neuropsychiatric disorders.

The Zipfel Lab aims to understand the mechanisms driving acute and chronic cerebrovascular diseases, identify new molecular targets, and develop novel therapies that will improve the lives of our patients.